246 related articles for article (PubMed ID: 2193142)
1. N-methyl-D-aspartate antagonism and phencyclidine-like activity: a drug discrimination analysis.
Koek W; Woods JH; Colpaert FC
J Pharmacol Exp Ther; 1990 Jun; 253(3):1017-25. PubMed ID: 2193142
[TBL] [Abstract][Full Text] [Related]
2. MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys.
Koek W; Woods JH; Winger GD
J Pharmacol Exp Ther; 1988 Jun; 245(3):969-74. PubMed ID: 2838610
[TBL] [Abstract][Full Text] [Related]
3. Behavioral pharmacological profile of CGS 19755, a competitive antagonist at N-methyl-D-aspartate receptors.
Bennett DA; Bernard PS; Amrick CL; Wilson DE; Liebman JM; Hutchison AJ
J Pharmacol Exp Ther; 1989 Aug; 250(2):454-60. PubMed ID: 2547931
[TBL] [Abstract][Full Text] [Related]
4. Effects of strychnine-insensitive glycine receptor ligands in rats discriminating dizocilpine or phencyclidine from saline.
Witkin JM; Steele TD; Sharpe LG
J Pharmacol Exp Ther; 1997 Jan; 280(1):46-52. PubMed ID: 8996180
[TBL] [Abstract][Full Text] [Related]
5. Tolerance to the cataleptic effect of the N-methyl-D-aspartate (NMDA) receptor antagonists in pigeons: cross-tolerance between PCP-like compounds and competitive NMDA antagonists.
Lu Y; France CP; Woods JH
J Pharmacol Exp Ther; 1992 Nov; 263(2):499-504. PubMed ID: 1432686
[TBL] [Abstract][Full Text] [Related]
6. Substitution for PCP, disruption of prepulse inhibition and hyperactivity induced by N-methyl-D-aspartate receptor antagonists: preferential involvement of the NR2B rather than NR2A subunit.
Chaperon F; Müller W; Auberson YP; Tricklebank MD; Neijt HC
Behav Pharmacol; 2003 Sep; 14(5-6):477-87. PubMed ID: 14501261
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological specificity of the discriminative stimulus properties of 2-amino-4,5-(1,2-cyclohexyl)-7-phosphono-heptanoic acid (NPC 12626), a competitive N-methyl-D-aspartate receptor antagonist.
Bobelis DJ; Balster RL
J Pharmacol Exp Ther; 1993 Feb; 264(2):845-53. PubMed ID: 8437128
[TBL] [Abstract][Full Text] [Related]
8. Antagonism of N-methyl-D-aspartate-induced transmitter release in the rat striatum by phencyclidine-like drugs and its relationship to turning behavior.
Snell LD; Johnson KM
J Pharmacol Exp Ther; 1985 Oct; 235(1):50-7. PubMed ID: 2864436
[TBL] [Abstract][Full Text] [Related]
9. The competitive N-methyl-D-aspartate (NMDA) antagonist CGS 19755 attenuates the rate-decreasing effects of NMDA in rhesus monkeys without producing ketamine-like discriminative stimulus effects.
France CP; Woods JH; Ornstein P
Eur J Pharmacol; 1989 Jan; 159(2):133-9. PubMed ID: 2651134
[TBL] [Abstract][Full Text] [Related]
10. Selective blockade of N-methyl-D-aspartate (NMDA)-induced convulsions by NMDA antagonists and putative glycine antagonists: relationship with phencyclidine-like behavioral effects.
Koek W; Colpaert FC
J Pharmacol Exp Ther; 1990 Jan; 252(1):349-57. PubMed ID: 2153806
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the discriminative stimulus effects of N-methyl- D-aspartate ligands under different ethanol training conditions in the cynomolgus monkey ( Macaca fascicularis).
Vivian JA; Waters CA; Szeliga KT; Jordan K; Grant KA
Psychopharmacology (Berl); 2002 Jul; 162(3):273-81. PubMed ID: 12122485
[TBL] [Abstract][Full Text] [Related]
12. Pentobarbital-like discriminative stimulus effects of N-methyl-D-aspartate antagonists.
Willetts J; Balster RL
J Pharmacol Exp Ther; 1989 May; 249(2):438-43. PubMed ID: 2542531
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the inhibition of excitatory amino acid-induced neurotransmitter release in the rat striatum by phencyclidine-like drugs.
Snell LD; Johnson KM
J Pharmacol Exp Ther; 1986 Sep; 238(3):938-46. PubMed ID: 2875174
[TBL] [Abstract][Full Text] [Related]
14. Discriminative stimulus effects of ethanol: effect of training dose on the substitution of N-methyl-D-aspartate antagonists.
Grant KA; Colombo G
J Pharmacol Exp Ther; 1993 Mar; 264(3):1241-7. PubMed ID: 8450461
[TBL] [Abstract][Full Text] [Related]
15. Phencyclidine selectively inhibits N-methyl-D-aspartate-induced hippocampal [3H]norepinephrine release.
Jones SM; Snell LD; Johnson KM
J Pharmacol Exp Ther; 1987 Feb; 240(2):492-7. PubMed ID: 2879908
[TBL] [Abstract][Full Text] [Related]
16. Competitive and noncompetitive N-methyl-D-aspartate antagonists modify hypoxia-induced membrane potential changes and protect rat hippocampal slices from functional failure: a quantitative comparison.
Grigg JJ; Anderson EG
J Pharmacol Exp Ther; 1990 Apr; 253(1):130-5. PubMed ID: 1970359
[TBL] [Abstract][Full Text] [Related]
17. Phencyclidine receptor ligands attenuate cortical neuronal injury after N-methyl-D-aspartate exposure or hypoxia.
Goldberg MP; Viseskul V; Choi DW
J Pharmacol Exp Ther; 1988 Jun; 245(3):1081-7. PubMed ID: 2838603
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the reinforcing and discriminative stimulus properties of the low-affinity N-methyl-D-aspartate channel blocker memantine.
Nicholson KL; Jones HE; Balster RL
Behav Pharmacol; 1998 May; 9(3):231-43. PubMed ID: 9832937
[TBL] [Abstract][Full Text] [Related]
19. (+)-N-Allylnormetazocine (NANM)-like discriminative stimulus effects of N-methyl-D-aspartate (NMDA) antagonists.
Willetts J; Rice A; Balster RL
Behav Pharmacol; 1990; 1(5):453-458. PubMed ID: 11175430
[TBL] [Abstract][Full Text] [Related]
20. Effects of competitive and noncompetitive N-methyl-D-aspartate (NMDA) antagonists in rats trained to discriminate NMDA from saline.
Willetts J; Balster RL
J Pharmacol Exp Ther; 1989 Nov; 251(2):627-33. PubMed ID: 2553930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
